Follow
Erik Roberson
Title
Cited by
Cited by
Year
Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia
AE Arrant, AJ Filiano, DE Unger, AH Young, ED Roberson
Brain 140 (5), 1447-1465, 2017
792017
Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia
BA Warmus, DR Sekar, E McCutchen, GD Schellenberg, RC Roberts, ...
Journal of Neuroscience 34 (49), 16482-16495, 2014
762014
Shared functions of perirhinal and parahippocampal cortices: implications for cognitive aging
SN Burke, LS Gaynor, CA Barnes, RM Bauer, JL Bizon, ED Roberson, ...
Trends in neurosciences 41 (6), 349-359, 2018
752018
Seizure resistance without parkinsonism in aged mice after tau reduction
Z Li, AM Hall, M Kelinske, ED Roberson
Neurobiology of aging 35 (11), 2617-2624, 2014
732014
A biochemical blueprint for long-term memory
ED Roberson, JD Sweatt
Learning & Memory 6 (4), 381-388, 1999
721999
Characterizing heterogeneity in neuroimaging, cognition, clinical symptoms, and genetics among patients with late-life depression
J Wen, CHY Fu, D Tosun, Y Veturi, Z Yang, A Abdulkadir, E Mamourian, ...
JAMA psychiatry 79 (5), 464-474, 2022
702022
Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration
JC Rojas, P Wang, AM Staffaroni, C Heller, Y Cobigo, A Wolf, SYM Goh, ...
Neurology 96 (18), e2296-e2312, 2021
682021
Protected‐site phosphorylation of protein kinase C in hippocampal long‐term potentiation
JD Sweatt, CM Atkins, J Johnson, JD English, ED Roberson, SJ Chen, ...
Journal of neurochemistry 71 (3), 1075-1085, 1998
681998
Non-coding and loss-of-function coding variants in TET2 are associated with multiple neurodegenerative diseases
JN Cochran, EG Geier, LW Bonham, JS Newberry, MD Amaral, ...
The American Journal of Human Genetics 106 (5), 632-645, 2020
642020
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
L Tan, HF Wang, MS Tan, CC Tan, XC Zhu, D Miao, WJ Yu, T Jiang, L Tan, ...
Scientific reports 6 (1), 26027, 2016
642016
Morphometricity as a measure of the neuroanatomical signature of a trait
MR Sabuncu, T Ge, AJ Holmes, JW Smoller, RL Buckner, B Fischl, ...
Proceedings of the National Academy of Sciences 113 (39), E5749-E5756, 2016
612016
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
AE Arrant, JR Roth, NR Boyle, SN Kashyap, MQ Hoffmann, CF Murchison, ...
Acta neuropathologica communications 7, 1-17, 2019
602019
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
JJ Tomlinson, B Shutinoski, L Dong, F Meng, D Elleithy, NA Lengacher, ...
Journal of neural transmission 124, 721-738, 2017
602017
Use of the CDR® plus NACC FTLD in mild FTLD: data from the ARTFL/LEFFTDS consortium
T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ...
Alzheimer's & Dementia, 2019
592019
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases
EM Ramos, DR Dokuru, V Van Berlo, K Wojta, Q Wang, AY Huang, ...
Alzheimer's & Dementia 16 (1), 118-130, 2020
562020
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)
AL Boxer, M Gold, E Huey, WT Hu, H Rosen, J Kramer, FB Gao, ...
Alzheimer's & Dementia 9 (2), 189-198, 2013
552013
Functional insights from biophysical study of TREM2 interactions with apoE and Aβ1‐42
DL Kober, MD Stuchell‐Brereton, CE Kluender, HB Dean, MR Strickland, ...
Alzheimer's & Dementia 17 (3), 475-488, 2021
532021
Mining outcome-relevant brain imaging genetic associations via three-way sparse canonical correlation analysis in Alzheimer’s disease
X Hao, C Li, L Du, X Yao, J Yan, SL Risacher, AJ Saykin, L Shen, ...
Scientific reports 7 (1), 44272, 2017
522017
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
AM Staffaroni, M Quintana, B Wendelberger, HW Heuer, LL Russell, ...
Nature medicine 28 (10), 2194-2206, 2022
502022
The Alzheimer's disease risk factor CD2AP maintains blood–brain barrier integrity
JN Cochran, T Rush, SC Buckingham, ED Roberson
Human molecular genetics 24 (23), 6667-6674, 2015
502015
The system can't perform the operation now. Try again later.
Articles 61–80